Welcome to DermaSensor Academy

Skin Cancer DETECTION, Simplified.

Please provide your full name (first and last) as you would like it to appear on your certificate.

Share, educate and collaborate with your staff and colleagues on DermaSensor’s technology

Skin cancer is the most common cancer in the United States. Current estimates are that 1 in 5 Americans will develop skin cancer in their lifetime. It is estimated that approximately 9,500 people in the U.S. are diagnosed with skin cancer every day.**

immediate

30 seconds to record lesion with immediate results*

*Clinical Evidence Upon Request

validated

96% sensitivity in detecting the three most common major types of skin cancer*

objective

Reduce the number of missed skin cancers by half, enhancing referral decisions*

First time on-boarding your device? Educating a new employee? Revisiting the fundamentals?

DermaSensor offers courses to help you brush up on your DermaSensor knowledge!

All Courses

Discover what other practitioners are saying.

We would love to hear from your patients about their experiences with Dermasensor, as their feedback is invaluable in understanding its impact on skin care assessments and overall satisfaction.

“In sunny Miami, skin cancer is a real concern. I’m excited to use a new non-invasive, FDA-cleared, AI-powered device to improve detection accuracy for high-risk patients”

Dr. Eduardo Alacron

“At Sanctum Med + Wellness, we deliver exceptional healthcare services prioritizing patient well-being and addressing every aspect of their health. Adding the DermaSensor device to our comprehensive range of services further underscores our commitment to staying at the forefront of medical innovation.”

Dr. Jessica Shepherd

” I am super excited to announce that we have a new device called DermaSensor at Montgomery Medical. I originally had the opportunity to work with DermaSensor through a clinical trial at Frontier Clinical Research. Now that it is FDA-cleared, we are excited to be one of the first PCP offices to offer this new technology that uses light to help us assess suspicious skin lesions. It is painless and only takes a few seconds to give us an immediate result.”

Dr. Marcy J. Goisse

“The DermaSensor device will be a great service to provide to my patients who are concerned about skin lesions, and an invaluable tool to help me decide how to manage their care.”

Dr. Dean Hildahl

Additional Resources

*Please note, the videos below are additional resources and not part of the DermaSensor Academy onboarding videos. To begin click below:

Click here to access DermaSensor Academy Onboarding Course

Introducing DermaSensor

DermaSensor’s Data-Driven Breakthrough Technology

How DermaSensor Works

DermaSensor’s Mission

Discover what other practitioners are saying.

We would love to hear from your patients about their experiences with Dermasensor, as their feedback is invaluable in understanding its impact on skin care assessments and overall satisfaction.

“In sunny Miami, skin cancer is a real concern. I’m excited to use a new non-invasive, FDA-cleared, AI-powered device to improve detection accuracy for high-risk patients”

Dr. Eduardo Alacron

Dr. Jessica Shepherd

Dr. Marcy J. Goisse

“The DermaSensor device will be a great service to provide to my patients who are concerned about skin lesions, and an invaluable tool to help me decide how to manage their care.”

Dr. Dean Hildahl

Guided Use Tutorials

The Essential DermaSensor Tutorial: Scoring System and Best Practices

DermaSensor Masterclass: Proper Technique with Dr. Gary Slatko

Interpreting DermaSensor Results: Beyond the Numbers with Dr. Slatko

Additional Resources

*Please note, the videos below are additional resources and not part of the DermaSensor Academy onboarding videos. To begin click below:

Click here to access DermaSensor Academy Onboarding Course

Introducing DermaSensor

DermaSensor’s Data-Driven Breakthrough Technology

How DermaSensor Works

DermaSensor’s Mission

FAQS

DermaSensor is designed to provide clinicians with objective, real-time evaluations of suspicious skin lesions. It helps in assessing cellular and sub-cellular characteristics that are not visible through traditional examination methods.

Click here to access IFU

Click here to access All Knowledge Base Resources – sign in required

The device is intended for use by non-dermatologist physicians rather than dermatologists. This is significant as it expands the capabilities of general practitioners in diagnosing skin cancer.

Click here to access IFU

Click here to access All Knowledge Base Resources – sign in required

Rapid Results: It provides immediate feedback on skin lesions, which can streamline the referral process.
High Sensitivity: In clinical studies, DermaSensor demonstrated a sensitivity of 96% for detecting the three most common skin cancers: basal cell carcinoma (BCC), squamous cell carcinoma (SCC) and melanoma.
User-Friendly: Its design allows for easy integration into busy medical practice
Click here to access IFU
Click here to access All Knowledge Base Resources – sign in required

DermaSensor employs a light-based technology that analyzes the scattering of light from skin lesions. This analysis helps determine the likelihood of malignancy, providing a spectral score for clinicians.

Click here to access IFU

Click here to access All Knowledge Base Resources – sign in required

While DermaSensor is a powerful tool, it is essential to consider the patient’s skin cancer history and other clinical factors when making a diagnosis. The device is not a replacement for a dermatologist’s evaluation but rather an adjunctive tool to aid in decision-making.

Click here to access IFU

Click here to access All Knowledge Base Resources – sign in required

Connect and follow us

** https://www.skincancer.org/skin-cancer-information/skin-cancer-facts/